July 23, 2010 – A new research and development center for medical imaging systems recently opened at University Hospitals Case Medical Center in northeastern Ohio. The Global Advanced Imaging Innovation Center brings together radiologic experts to coordinate clinical research, education, development and commercialization of advanced imaging technologies.

The center was opened in partnership with Philips Healthcare and Case Western Reserve University. It is funded in part by a $5 million Ohio Third Frontier grant to Case Western Reserve University with additional support of $33.4 million from Philips Healthcare. The center is will be housed on the campus of University Hospitals Case Medical Center, providing the latest imaging technologies and treatments to patients with cancer, neurologic conditions and heart disease.

The center is designed to move innovative technologies more quickly into patient care. The latest Philips imaging equipment will be brought to Cleveland for development, validation of clinical efficacy and product release. The center is expected to become an international hub for education in these cutting edge medical technologies. Many of Philips’ newest technologies will be tested at the site.

One of the world’s first PET/MRI (positron emission tomography/magnetic resonance imaging) machines will be housed in the future University Hospitals Cancer Hospital, opening in the spring of 2011. This hybrid scanner is in a new class of diagnostic imaging that captures both functional and anatomical information. The PET/MRI brings together the complementary capabilities of MRI and PET scanning to potentially improve patient care by increasing understanding of the causes, effects, and development of disease processes to better diagnose and treat the condition.

A new generation of PET/CT that will improve the dual function of this technology and increase diagnostic imaging capabilities, specifically with cancer. PET detects metabolic signals in the body while CT provides a detailed picture of the internal anatomy. The combined image provides more complete information on cancer location and metabolism and key applications in heart disorders.

A new PET scanner that is an even more powerful diagnostic tool that helps in the diagnosis and treatment of certain diseases, such as cancer and Alzheimer’s. This new PET imaging system can reveal metabolic changes in the body not currently detectable with today’s technology.


Related Content

News | Radiology Imaging

June 15, 2026 — Lead Glass Pro, a supplier of radiation shielding products, has expanded its turnkey installation ...

Time June 18, 2026
arrow
Feature | Magnetic Resonance Imaging (MRI)

The majority of MRI scanners require about 1,500 liters of liquid helium to operate, but geopolitical unrest is putting ...

Time June 17, 2026
arrow
News | PET-MRI

June 10, 2026 — UTHealth Houston has launched a state-of-the-art PET/MRI imaging service, bringing together two advanced ...

Time June 12, 2026
arrow
News | Innovative Hospitals

May 27, 2026 — Nearly two years after announcing plans for a “real-world” academic-industrial collaboration, GE ...

Time June 03, 2026
arrow
News | Nuclear Imaging

June 1, 2026 — At the 2026 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, GE HealthCare will ...

Time June 02, 2026
arrow
News | Radiopharmaceuticals and Tracers

June 1, 2026 — Serac Healthcare Ltd. has presented Phase 2 data showing that SPECT-CT imaging with the radiotracer 99mTc ...

Time June 01, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | Radiology Imaging

May 18, 2026 — DICO, a company specializing in the creation of distributed diagnostic infrastructure for radiology, has ...

Time May 19, 2026
arrow
News | Radiopharmaceuticals and Tracers

May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...

Time May 08, 2026
arrow
Subscribe Now